Asian Paints:2,671.60-0.27 (-0.01%)
Cipla:1,401.00-17.16 (-1.21%)
Eicher Motors:7,177.00-241.85 (-3.26%)
Nestle India:1,421.50-6.00 (-0.42%)
Grasim Inds:3,122.40-47.55 (-1.50%)
Hindalco Inds.:1,126.70-22.99 (-2.00%)
Hind. Unilever:2,153.50-44.85 (-2.04%)
ITC:286.90-5.05 (-1.73%)
Trent:4,224.00-24.64 (-0.58%)
Larsen & Toubro:4,076.50+29.14 (+0.72%)
M & M:3,045.60-75.85 (-2.43%)
Reliance Industries:1,321.20-29.31 (-2.17%)
Tata Consumer:1,178.40-26.14 (-2.17%)
Tata Motors PVeh:393.90-7.06 (-1.76%)
Tata Steel:208.02-6.68 (-3.11%)
Wipro:204.25+2.66 (+1.32%)
Apollo Hospitals:8,176.50-95.96 (-1.16%)
Dr Reddy's Labs:1,303.50-15.56 (-1.18%)
Titan Company:4,074.90-62.89 (-1.52%)
SBI:964.40-3.39 (-0.35%)
Shriram Finance:947.15-16.09 (-1.67%)
Bharat Electron:410.75-8.34 (-1.99%)
Kotak Mah. Bank:384.20-4.51 (-1.16%)
Infosys:1,160.90+1.04 (+0.09%)
Bajaj Finance:908.25-22.91 (-2.46%)
Adani Enterp.:2,937.40-35.68 (-1.20%)
Sun Pharma.Inds.:1,799.20-45.19 (-2.45%)
JSW Steel:1,278.00-31.29 (-2.39%)
HDFC Bank:744.55-14.11 (-1.86%)
TCS:2,258.90-25.36 (-1.11%)
ICICI Bank:1,256.40-16.29 (-1.28%)
Power Grid Corpn:290.55-9.60 (-3.20%)
Maruti Suzuki:13,127.00-236.53 (-1.77%)
Axis Bank:1,286.60-17.47 (-1.34%)
HCL Technologies:1,183.80+18.64 (+1.60%)
O N G C:265.40-8.66 (-3.16%)
NTPC:386.90-11.27 (-2.83%)
Coal India:457.90-5.14 (-1.11%)
Bharti Airtel:1,829.00-23.15 (-1.25%)
Tech Mahindra:1,483.90+28.24 (+1.94%)
Jio Financial:238.95-3.93 (-1.62%)
Adani Ports:1,804.60-19.89 (-1.09%)
HDFC Life Insur.:594.80-14.81 (-2.43%)
SBI Life Insuran:1,830.10-34.31 (-1.84%)
Max Healthcare:965.10-28.31 (-2.85%)
UltraTech Cem.:11,482.00-206.89 (-1.77%)
Bajaj Auto:10,460.00-348.02 (-3.22%)
Bajaj Finserv:1,783.60-25.51 (-1.41%)
Interglobe Aviat:4,405.00-164.98 (-3.61%)
Eternal:250.58-5.93 (-2.31%)
Asian Paints:2,671.60-0.27 (-0.01%)
Cipla:1,401.00-17.16 (-1.21%)
Eicher Motors:7,177.00-241.85 (-3.26%)
Nestle India:1,421.50-6.00 (-0.42%)
Grasim Inds:3,122.40-47.55 (-1.50%)
Hindalco Inds.:1,126.70-22.99 (-2.00%)
Hind. Unilever:2,153.50-44.85 (-2.04%)
ITC:286.90-5.05 (-1.73%)
Trent:4,224.00-24.64 (-0.58%)
Larsen & Toubro:4,076.50+29.14 (+0.72%)
M & M:3,045.60-75.85 (-2.43%)
Reliance Industries:1,321.20-29.31 (-2.17%)
Tata Consumer:1,178.40-26.14 (-2.17%)
Tata Motors PVeh:393.90-7.06 (-1.76%)
Tata Steel:208.02-6.68 (-3.11%)
Wipro:204.25+2.66 (+1.32%)
Apollo Hospitals:8,176.50-95.96 (-1.16%)
Dr Reddy's Labs:1,303.50-15.56 (-1.18%)
Titan Company:4,074.90-62.89 (-1.52%)
SBI:964.40-3.39 (-0.35%)
Shriram Finance:947.15-16.09 (-1.67%)
Bharat Electron:410.75-8.34 (-1.99%)
Kotak Mah. Bank:384.20-4.51 (-1.16%)
Infosys:1,160.90+1.04 (+0.09%)
Bajaj Finance:908.25-22.91 (-2.46%)
Adani Enterp.:2,937.40-35.68 (-1.20%)
Sun Pharma.Inds.:1,799.20-45.19 (-2.45%)
JSW Steel:1,278.00-31.29 (-2.39%)
HDFC Bank:744.55-14.11 (-1.86%)
TCS:2,258.90-25.36 (-1.11%)
ICICI Bank:1,256.40-16.29 (-1.28%)
Power Grid Corpn:290.55-9.60 (-3.20%)
Maruti Suzuki:13,127.00-236.53 (-1.77%)
Axis Bank:1,286.60-17.47 (-1.34%)
HCL Technologies:1,183.80+18.64 (+1.60%)
O N G C:265.40-8.66 (-3.16%)
NTPC:386.90-11.27 (-2.83%)
Coal India:457.90-5.14 (-1.11%)
Bharti Airtel:1,829.00-23.15 (-1.25%)
Tech Mahindra:1,483.90+28.24 (+1.94%)
Jio Financial:238.95-3.93 (-1.62%)
Adani Ports:1,804.60-19.89 (-1.09%)
HDFC Life Insur.:594.80-14.81 (-2.43%)
SBI Life Insuran:1,830.10-34.31 (-1.84%)
Max Healthcare:965.10-28.31 (-2.85%)
UltraTech Cem.:11,482.00-206.89 (-1.77%)
Bajaj Auto:10,460.00-348.02 (-3.22%)
Bajaj Finserv:1,783.60-25.51 (-1.41%)
Interglobe Aviat:4,405.00-164.98 (-3.61%)
Eternal:250.58-5.93 (-2.31%)

Arihant Plus App

Glaxosmithkline Pharmaceuticals Ltd

Glaxosmi. Pharma | 500660

Market Closed
2,210.20
86.11 (-3.75%)
As on 30/05/26, 1:15 PM
Market Cap37,442.12 CR
Current Price₹2,210.2
High / Low₹3,515.7 / 2,194.4
PE Ratio52.54
Book Value₹115.19
Dividend Yield1.88%
ROCE59.29%
ROE49.23%
Face Value₹2.00
Current Vol.3,04,042
Average Vol.---
ISININE159A01016
PB Ratio24.98
Debt to Equity0.01
Net Profit Margin24.74
Operating Margin35.42

Stock Charts

📊

No Information Available

Stock charts information is not available at this time.

Stock Performance

2,4802,490
2,500
Previous CloseToday's Open
1,8003,000
2,500
52W Low52W High
₹2,480Today's Open
₹2,490Previous Close
12,00,000Volume
₹1,80052W Low
₹3,00052W High

Ratios

No data available

About Company

  • GlaxoSmithKline Pharmaceuticals Limited was erstwhile incorporated as 'Glindia Limited' in November, 1924
  • The Company' s name was changed to Glaxo (India) Limited' from Glindia Limited in year 1987 and further to 'GlaxoSmithKline Pharmaceuticals Limited' from Glaxo (India) Limited effective from October 22, 2001
  • GlaxoSmithKline Pharmaceuticals Limited is a subsidiary of UK-based GSK Plc
  • , a global biopharma company to unite science, technology and talent to get ahead of disease together
  • The Company is headquartered in Mumbai and it has six branch offices, one manufacturing facility at Nashik in Maharashtra, 20 contract manufacturing organisations (CMOs) with regional and sales hubs across India
  • The Company is engaged interalia, in the business of manufacturing, distributing and trading in pharmaceuticals
  • The Company's portfolio includes General Medicines, Vaccines and Specialty medicines that help prevent and treat disease
  • Their prescription medicines range across therapeutic areas, such as Anti-Infectives, Dermatology, Gynaecology, Diabetes, Oncology, Cardiovascular Disease and Respiratory Diseases
  • They also offer a range of vaccines, for the prevention of Hepatitis A, Hepatitis B, Invasive Disease caused by H, Influenza, Chickenpox, Diphtheria, Pertussis, Tetanus, Rotavirus, Cervical Cancer and Others
  • They have two manufacturing units in India, located at Nashik and Thane

Ethics: Glaxosmithkline Pharmaceuticals Ltd is flagged for

paw image

Animal Cruelty

The company engages directly in some form of animal cruelty through its business.

Research Calls

Research Calls
Locked Access

Explore all active research calls & maximize your profits

To access, login or signup with ArihantPlus

Technical Indicators

RSI29.05
SMA 202371.31
SMA 502379.24
SMA 1002429.35
SMA 2002544.70
SMA 102328.13
MACD_12_26_Days-38.70
EMA10Day2313.66
EMA20Day2351.14
EMA50Day2392.35
MACD_12_26_9_Days-18.34
EMA100Day2443.61
EMA200Day2530.90

Pivot Points

Volume Analysis

Delivery
Total Volume

Growth Rate

Revenue Growth8.56%
ROE49.75%
EBITDA Margin35.42%

All figures in ₹ Crores

Indicators20252024202320222021
Revenue
3,749.21
3,453.71
3,251.72
3,278.03
2,925.60
Interest
1.31
1.80
1.81
2.00
3.53
Expenses
2,571.85
2,545.02
2,447.44
2,516.15
2,327.46
Financing Profit
1,323.29
1,031.28
904.95
837.65
708.72
Financing Margin %
35%
30%
28%
26%
24%
Other Income
145.93
122.59
100.66
75.78
110.58
Depreciation
66.79
69.68
65.77
68.19
78.60
Profit before tax
1,259.88
816.19
836.40
779.05
453.99
Tax %
26%
28%
27%
51%
37%
Net Profit
927.58
589.96
607.64
380.77
287.27
EPS in Rs
54.76
34.83
36.05
100.04
21.14
Show % Change
ShareHolding
📊

No Information Available

No shareholding data available at this time.

DealDateTypeQuantityPriceTraded %
ISHARES CORE EMERGING MARKETS MAURITIUS CO03 Oct ‘22Sell77,4391,424.4165.47%
ISHARES CORE MSCI EMERGING MARKETS ETF03 Oct ‘22Purchase77,4391,424.4165.47%
ISHARES INDIA SC MAURITIUS COMPANY03 Oct ‘22Sell11,3731,424.424.30%
ISHARES MSCI INDIA SMALL-CAP ETF03 Oct ‘22Purchase11,3731,424.424.30%

News

📊

No Information Available

No news available for this company.
Record Date
Corporate Action
Information
Announcement Day
29 May 2026
Final Dividend (₹57)
The Board has recommended a final dividend of Rs.57/- per equity share on face value of Rs.10 each for the year ended 31st March 2026, subject to approval of members at 101 st Annual General Meeting
13 May 2026
27 Jun 2025
AGM
AGM
13 May 2025
30 May 2025
Final Dividend (₹42)
The Board has recommended a final dividend of Rs.42/- per equity share on face value of Rs .10 each for the year ended 31 st March 2025, subject to approval of members at 100th Annual General Meeting
13 May 2025
07 Nov 2024
Special Dividend (₹12)
Outcome of Meeting The Board has recommended Special Interim dividend of Rs. 12/- (120%) per equity share on face value of Rs.10 each of the Company.
29 Oct 2024
28 Jun 2024
AGM
AGM
17 May 2024
31 May 2024
Final Dividend (₹32)
The Board has recommended a dividend of Rs. 32/- per equity share on face value of Rs.10 each for the year ended 31st March 2024, subject to approval of members at 99th Annual General Meeting.
17 May 2024
26 Jul 2023
AGM
AGM
30 May 2023
30 Jun 2023
Final Dividend (₹32)
Board has recommended a dividend of Rs. 32/- per equity share on face value of Rs.10 each for the year ended 31 st March 2023, subject to approval of members at 98th Annual General Meeting.
17 May 2023
26 Jul 2022
AGM
AGM
16 May 2022
08 Jul 2022
Final Dividend (₹30)
Board approved: 1. Dividend The Board has recommended a dividend of Rs. 90/- (including special dividend of Rs. 60) per equity share on face value of Rs.10 each for the year ended 31 st March 2022, subject to approval of members at 97th Annual General Meeting to be held on Tuesday, 26th July, 2022. Pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company has fixed Friday, 8th July, 2022 as the Record Date for determining entitlement of members to final dividend for the financial year ended 31 st March, 2022. The dividend, if approved by the members will be paid on or after Wednesday, 27th July, 2022.
16 May 2022

Peers

LTP(₹)
Market Cap(₹ Cr.)
P/E Ratio(Ratio)
P/B Ratio(Ratio)
Cash Earnings(Ratio)
Debt to Equity(Ratio)
Net Profit Ratio(%)
2,209
37,417
37
17
34
0
24.74%
1,801
4,32,096
35
5
28
0
20.88%
6,660
1,76,807
67
11
57
0
23.41%
4,394
1,48,718
68
18
45
1
16.60%
1,399
1,12,971
28
3
21
0
19.21%
1,303
1,08,752
26
3
17
0
17.54%
1,078
1,08,442
20
4
16
0
19.86%
2,272
1,03,900
18
5
15
0
14.56%
2,378
98,179
49
6
34
0
14.39%
1,431
83,107
23
2
16
0
10.98%
Showing 10 of 131 Results

Frequently Asked Questions

What is Share Price of Glaxosmithkline Pharmaceuticals Ltd?

The current share price of Glaxosmithkline Pharmaceuticals Ltd (Glaxosmi. Pharma) is ₹2210.20. This price reflects the latest market valuation and is updated in real-time during trading hours.

What is the P/E Ratio of Glaxosmithkline Pharmaceuticals Ltd?

The Price-to-Earnings (P/E) ratio of Glaxosmithkline Pharmaceuticals Ltd is 2210.20. This indicates how much investors are willing to pay per rupee of earnings, helping assess if the stock is overvalued or undervalued.

What is the 52-week high and low of Glaxosmithkline Pharmaceuticals Ltd?

Glaxosmithkline Pharmaceuticals Ltd has a 52-week high of ₹3515.70 and a 52-week low of ₹2194.40. This range shows the stock's price volatility over the past year.

What is the Dividend Yield of Glaxosmithkline Pharmaceuticals Ltd?

Glaxosmithkline Pharmaceuticals Ltd offers a dividend yield of 2.58%. This represents the annual dividend payment as a percentage of the current stock price, indicating the income return for investors.

What is the EPS of Glaxosmithkline Pharmaceuticals Ltd?

The Earnings Per Share (EPS) of Glaxosmithkline Pharmaceuticals Ltd is ₹60.26. EPS indicates the company's profitability on a per-share basis and is a key metric for evaluating financial performance.

What is the ROE of Glaxosmithkline Pharmaceuticals Ltd?

Glaxosmithkline Pharmaceuticals Ltd has a Return on Equity (ROE) of 49.23%. ROE measures how effectively the company uses shareholders' equity to generate profits, with higher values generally indicating better performance.

Disclaimer:

Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.

mobile

Ready to invest smarter?
Download the app today.

app store

GET IT ON

Google Play

4.5

app store

DOWNLOAD ON THE

App Store

4.2